Search Results

1 - 10 of 1,973 items :

  • "formulations" x
Clear All
Lipid Based Formulations of Biopharmaceutics Classification System (BCS) Class II Drugs: Strategy, Formulations, Methods and Saturation

REFERENCES 1. Driscoll, C. M. O., 2002: Lipid based formulations for intestinal lymphatic delivery. Eur. J. Pharm. Sci. ,15, 405—415. 2. Hulling, Mu., Holm, R., Mullertz, A., 2013: Lipid-based formulations for oral administration of poorly water-soluble drugs. Int. J. Pharm. , 453, 215—224. 3. Humberstone, A. J., Charman, W. N., 1995: Lipid-based vehicles for the oral delivery of poorly water soluble drugs. Adv. Drug Deliv. Rev. , 25, 103—128. 4. Charman, W. N., Porter, C. J., Mithani, S., Dressman, J. B., 1997: Physicochemical and

Open access
Zero crossing and ratio spectra derivative spectrophotometry for the dissolution tests of amlodipine and perindopril in their fixed dose formulations

and amlodipine in pharmaceutical formulation in the presence of their degradation products, J. Chromatogr. Sci., 51, 533, 2013.

Open access
Weak Formulation Study For Thermoelastic Buckling Analysis Of Thick Laminated Cylindrical Shells

analytical levy-type solution . – Journal of Thermal Stresses, vol.16, pp.401-419. Civalek and Omer (2013): Vibration analysis of laminated composite conical shells by the method of discrete singular convolution based on the shear deformation theory . – Composites Part B: Engineering, vol.45, No.1, pp.1001-1009. Ding Kewei (2000): Symplectic algorithm method for Hamiltonian matrix eigenvalue and eigenvector problem . – Journal of Hefei University of Technology, vol.23, No.3, pp.336-340 (in Chinese). Ding Kewei (2005): Weak formulation study of thick

Open access
Micellar liquid chromatographic analysis of benzyl alcohol and benzaldehyde in injectable formulations

References A. G. Kazemifard, D. E. Moore and A. Mohammadi, Polarographic determination of benzaldehyde in benzyl alcohol and sodium diclofenac injection formulations, J. Pharm. Biomed. Anal. 30 (2002) 257-262; DOI: 10.1016/S0731-7085(02)00340-0. M. A. El-Ries, Spectrophotometric and indirect determination of lincomycin by atomic absorption spectroscopy (AAS), Anal. Lett. 27 (1994) 1517-1531. Y. C. de-Micalizzi, N. B. Pappano and N. B. Debattista, First and second order

Open access
1. Formulation in Action: An Introduction
Open access
Comparison of high-performance thin layer chromatography/UV-densitometry and UV-derivative spectrophotometry for the determination of trimetazidine in pharmaceutical formulations

, Metabolism 65 (2016) 122–130; https://doi.org/10.1016/j.metabol.2015.10.022 5. A. Onay-Besikci and S. A. Özkan, Trimetazidine revisited: A comprehensive review of the pharmacological effects and analytical techniques for the determination of trimetazidine, Cardiovasc. Ther. 26 (2008) 147–165; https://doi.org/10.1111/j.1527-3466.2008.00043.x 6. T. K. Murthy, G. D. Sankar and S. R. Yarraguntla, Visible spectrophotometric methods for the determination of trimetazidine dihydrochloride in pharmaceutical formulations, Indian Drugs 39 (2002) 230

Open access
Determination of loratadine in pharmaceuticals by a spectrophotometric method

Abstract

The spectrophotometric method for determination of loratadine using tetraiodomercurate has been applied in various pharmaceutical formulations. The results confirmed that recovery value is optimum and the method is valid, thus it can be used in quality control and evaluation of loratadine tablets, oral formulations of mixed composition, oral solutions, etc. The method is easy and simple to apply, does not require complicated equipment and spectrophotometric reading time is reduced, which allows a large number of analyzes in a relatively short time.

Open access
Formulation and evaluation of mucoadhesive glipizide films

References S. Baumgartner and J. Kristl, Optimisation of floating matrix tablets and evaluation of their gastric residence time, Int. J. Pharm.   195 (2000) 125-135; DOI: 10.1016/S0378-5173(02)00022-4. A. Streubel, J. Siepmann and R. Bodmeier, Floating matrix tablets based on low-density foam powder: effects of formulation and processing parameters on drug release, Eur. J. Pharm. Sci.   18 (2003) 37-45; DOI: 10.1016/S0928-0987(02)00223-3. J. K. Patel and J. R. Chavda

Open access
Topical antifungal bigels: Formulation, characterization and evaluation

HCL, Asian J. Pharm. Sci. 8 (2013) 46–54; https://doi.org/10.1016/j.ajps.2013.07.006 13. A. Kaur, S. Jaiswal and G. D. Gupta, Formulation and evalution of terbinafine hydrochloride topical gel, Indo. Am. J. Pharm. Res. 4 (2014) 2919–2927. 14. M. E. Herbig and D. H. Evers, Correlation of hydrotropic solubilization by urea with log D of drug molecules and utilization of this effect for topical formulations, Eur. J. Pharm. Biopharm. 85 (2013) 158–160; https://doi.org/10.1016/j.ejpb.2013.06.022 15. J. Leyden, Pharmacokinetics and

Open access
Curcumin phytosomal softgel formulation: Development, optimization and physicochemical characterization

, Langmuir. 24 (2008) 5672–5675; DOI: 10.1021/la800780w. 6. T. H. Kim, H. H. Jiang, Y. S. Youn, C. W. Park, K. K. Tak, S. Lee, H. Kim and S. Y. Jon, Preparation and characterization of water-soluble albumin bound curcumin nanoparticles with improved antitumor activity, Int. J. Pharm. 403 (2011) 285–591; DOI: 10.1016/j.ijpharm.2010.10.041. 7. Y. B. Pawar, H. Purohit, G. Valicherla, B. Munjal, S. V. Lale, S. Patel and A. K. Bansal, Novel lipid based oral formulation of curcumin: development and optimization by design of experiments approach, Int. J. Pharm

Open access